MiR-1246 Promotes Metastasis and Invasion of A549 Cells by Targeting GSK-3β–Mediated Wnt/β-Catenin Pathway

다국어 초록 (Multilingual Abstract)

Purpose MicroRNAs (miRNAs) are a group of small non-coding RNAs involved in different cancers, including lung cancer. Here, we aim to investigate the expression profiles of circulating miRNAs and their roles contributed to the progress of lung cancer.
Materials and Methods The levels of circulating miRNA in lung cancer patients were investigated by miRNAs assay.
Then we predicted the target genes of aberrantly expressing miRNAs by searching genetic databases. Based on the A549 cells transfected with miR-1246 mimics or miR-1246 inhibitor, we further measured the roles of miR-1246 involving in the epithelial-mesenchymal transition (EMT), migration and invasion capacities of lung cancer cells in vitro. Finally, we detected the effects of miR-1246 on glycogen synthase kinase-3β (GSK-3β)/β-catenin pathway by immunofluorescence and Western blot, respectively.
Results We identified that 14 miRNAs were aberrantly expressed in the serum of lung cancer patients.
Among them, miR-1246 was the most up-regulated. The cell assays indicated that miR-1246 significantly increased the migration and invasion capabilities of A549 lung cancer cells. Meanwhile, immunofluorescence analysis revealed that miR-1246 promoted EMT process of A549 cells accompanying with decreasing E-cadherin expression, while increasing vimentin and transforming growth factor β expression. Furthermore, an online tool predicated that miR-1246 might bind to 3'-untranslated region of GSK-3β, which was confirmed by overexpression and knockdown of miR-1246 assays.
Conclusion Taken together, the study illustrates that miR-1246 regulates Wnt/β-catenin pathway through targeting GSK-3β/β-catenin, which partly contributing to tumor metastasis. MiR- 1246 may play an essential role in the diagnosis and therapeutic of lung cancer.

참고문헌 (Reference)

1 Baranwal S, "miRNA control of tumor cell invasion and metastasis" 126 : 1283-1290, 2010

2 Song L, "miR-144-5p enhances the radiosensitivity of non-small-cell lung cancer cells via targeting ATF2" 2018 : 5109497-, 2018

3 Jia Z, "miR-126 suppresses epithelial-to-mesenchymal transition and metastasis by targeting PI3K/AKT/Snail signaling of lung cancer cells" 15 : 7369-7375, 2018

4 Skronska-Wasek W, "WNT receptor signalling in lung physiology and pathology" 187 : 150-166, 2018

5 Zhang WC, "Tumour-initiating cell-specific miR-1246 and miR-1290expression converge to promote non-small cell lung cancer progression" 7 : 11702-, 2016

6 Sung WJ, "The biological role of epithelialmesenchymal transition in lung cancer(Review)" 36 : 1199-1206, 2016

7 Krishnamurthy N, "Targeting the Wnt/beta-catenin pathway in cancer : update on effectors and inhibitors" 62 : 50-60, 2018

8 Martinez-Rivera V, "Secreted and tissue miRNAs as diagnosis biomarkers of malignant pleural mesothelioma" 19 : E195-, 2018

9 Arif Uddin, "Role of miRNAs in lung cancer" Wiley 2018

10 Otsuki Y, "Prospects for new lung cancer treatments that target EMT signaling" 247 : 462-472, 2018

11 Bica-Pop C, "Overview upon miR-21 in lung cancer : focus on NSCLC" 75 : 3539-3551, 2018

12 Chai S, "Octamer 4/microRNA-1246 signaling axis drives Wnt/betacatenin activation in liver cancer stem cells" 64 : 2062-2076, 2016

13 Kodahl AR, "Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer : a case control study" 8 : 874-883, 2014

14 Jiang W, "MicroRNA-1258 suppresses tumour progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer" 51 : e12502-, 2018

15 Lin G, "MiR-26a enhances invasive capacity by suppressing GSK3beta in human lung cancer cells" 352 : 364-374, 2017

16 Reck M, "Metastatic non-small-cell lung cancer (NSCLC):ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up" 25 (25): iii27-iii39, 2014

17 Wu KL, "Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib" 88 : 187-194, 2015

18 Tanaka K, "Intracellular signals of lung cancer cells as possible therapeutic targets" 106 : 489-496, 2015

19 Kim G, "HsamiR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer" 91 : 15-22, 2016

20 Yuan D, "Extracellular miR-1246 promotes lung cancer cell proliferation and enhances radioresistance by directly targeting DR5" 7 : 32707-32722, 2016

21 Nowrin K, "Epithelial-mesenchymal transition as a fundamental underlying pathogenic process in COPD airways : fibrosis, remodeling and cancer" 8 : 547-559, 2014

22 Yang Y, "Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/beta-catenin signaling in non-small-cell lung cancer" 57 : 842-853, 2018

23 Li L, "Clinical significance of blood-based miRNAs as biomarkers of non-small cell lung cancer" 15 : 8915-8925, 2018

24 Mitchell PS, "Circulating microRNAs as stable blood-based markers for cancer detection" 105 : 10513-10518, 2008

25 Moshiri F, "Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma" 9 : 15350-15364, 2018

26 Ortiz-Quintero B, "Cell-free microRNAs in blood and other body fluids, as cancer biomarkers" 49 : 281-303, 2016

27 김슬기, "Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib" 대한암학회 51 (51): 951-962, 2019